Topical pentoxifylline can be an effective and safe adjunctive therapy to NBUVB therapy in treating vitiligo: A split-side clinical trial

Exp Dermatol. 2022 Feb;31(2):255-256. doi: 10.1111/exd.14436. Epub 2021 Jul 30.

Nasrin Saki^{1

2}, Elham Sheikhi Ghayur^{1

2}, Alireza Heiran³, Mahsa Gholami⁴, Shohreh Alipour^{5

6}

¹ Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
² Dermatology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
³ Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
⁴ Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
⁵ Department of Quality Control, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
⁶ Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

No abstract available

Keywords: NBUVB; pentoxifylline; phototherapy; tacrolimus; vitiligo.

Publication types